Synthesis, antiviral and cytotoxic investigation of 2-phenyl-3-substituted quinazolin-4(3H)-ones

European Review for Medical and Pharmacological Sciences

Volumn 15, Issue 6, 2011, Pages 673-681

  Krishnan, Suresh Kumar ^a   Ganguly, S ^b   Veerasamy, R ^c   Jan, B ^d  

^a KMCH COLLEGE OF PHARMACY   (India)

^b BIRLA INSTITUTE OF TECHNOLOGY   (India)

^c AIMST UNIVERSITY   (Malaysia)

^d REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Antiviral activity; Herpes simplex; Quinazoline; Vaccinia virus; Vesicular stomatitis virus and influenza virus

Indexed keywords

3 (BENZYLIDENEAMINO) 2 PHENYLQUINAZOLIN 4(3H) ONE DERIVATIVE; 3 [(3,4 DIMETHOXYBENZYLIDENE)AMINO] 2 PHENYL 3H QUINAZOLIN 4 ONE; QUINAZOLINONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DNA VIRUS; DRUG CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; NONHUMAN; REACTION ANALYSIS; RNA VIRUS; STRUCTURE ANALYSIS; VERO CELL; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CATS; CELL LINE; CERCOPITHECUS AETHIOPS; DOGS; HELA CELLS; HUMANS; QUINAZOLINONES; STRUCTURE-ACTIVITY RELATIONSHIP; VERO CELLS; VIRUS DISEASES; VIRUS REPLICATION;

EID: 79960380091     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. DINAKARAN M, SELVAM P, CLERCQ ED, SRIDHAR SK. Synthesis, antiviral and cytotoxic activity of 6-bromo-2,3-disubstituted-4(3H)-quinazolinones. Biol Pharm Bull 2003; 26: 1278-1282.
2. SCHLEISS M, EICKHOFF J, AUEROCHS S, LEIS M, ABELE S, RECHTER S, CHOI Y, ANDERSON J, SCOTT G, RAWLINSON W, MICHEL D, ENSMINGER S, KLEBL B, STAMMINGER T, MARSCHALL M. Protein kinase inhibitors of the quinazoline class exert anti-cytomegaloviral activity in vitro and in vivo. Antiviral Res 2008; 79: 49-61.
3. SELVAM P, VUAYALAKSHMI P, SMEE DF, GOWEN BB, JULANDER JG, DAY CW, BARNARD DL. Novel 3-sulphonamido-quinazolin-4(3H)-one derivatives: microwave-assisted synthesis and evaluation of antiviral activities against respiratory and biodefense viruses. Antivir Chem Chemother 2007; 18: 301-305.
4. SELVAM P, BABU K, PADAMRAJ R, PERSOONS L, CLERCQ ED. Synthesis, antiviral and cytotoxic activities of some novel 2-phenyl-3-disubstituted quinazolin-4(3H)-ones. Afr J Pharm Pharmacol 2008; 2: 110-115.
5. KUMAR KS, GANGULY S, RAVICHANDRAN V, DE CLERCQ E. Synthesis, antiviral activity and cytotoxicity evaluation of Schiff bases of some 2-phenyl quinazo-line-4(3)H-ones. Eur J Med Chem 2010; 45: 5474-5479.
6. CORBETT JW, RODGERS JD. Discovery of second generation quinazolinone non-nucleoside reverse transcriptase inhibitors of HIV-1. Prog Med Chem 2002; 40: 63-105.
7. DESAI NC, UNDAVIA NK, TRIVEDI PB, DAVE D, VYAS GD. Synthesis and anti-HIV activity of some non-nucleoside 2,3-disubstituted quinazoline derivatives (Part-V). Indian J Exp Biol 1998; 36: 1280-1283.
8. PANDEYA SN, SRIRAM D, NATH G, CLERCQ ED. Synthesis, antibacterial, antifungal and anti-HIV evaluation of Schiff and Mannich bases of isatin derivatives with 3-amino-2-methylmercapto quinazolin-4(3H)-one. Pharm Acta Helv 1999; 74: 11-17.
9. GIRLIA K, SELVAM P, NAGARAJAN R. Synthesis anti-cancer activity of 3-[5-Amino-6-(2,3-dichlorophenyl)-[1,2,4]triazin-3-yl]-6,8-dibromo-2- substituted-3H-quinazolin-4-one. Asian J Chem 2005; 17: 1111-1115.
10. MURUGAN V, PADMAVATHY NP, RAMASARMA GVS, SHARMA SV, SURESH B. Synthesis of some quinazolinone derivatives as possible anticancer agent. Indian J Heterocyclic Chem 2003; 13: 143-146.
11. ANJANI KT, VINAY KUMAR S, ARUNA B, GAURI S, SWETA S, ANIL KM. Synthesis and biological properties of 4-(3H)-quinazoline derivatives. Eur J Med Chem 2008; 42: 1234-1238.
12. DE CLERCQ E. In-vitro and ex vivo test systems to rationalize drug design and delivery. In Minutes of an European Symposium, Eds. Crommelin D, Couvreur P, Duchene D. Editions de Sante, Paris, 1994, pp. 108-125.
13. PANDEYA SN, SMITHA S, JYOTI M, SRIDHAR SK. Biological activities of isatin and its derivatives. Acta Pharm 2005; 55: 27-46.
14. SELVAM P, MURUGESH N, CHANDRAMOHAN M, SIDWELL RW, WANDERSEE MK, SMEE DF. Anti-influenza virus activities of 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene) amino]-N-(4,6-dimethyl-2-pyrimidin-2-yl)benzenesulphonamide and its derivatives. Antivir Chem Chemother 2006; 17: 269-274.
15. SIN N, VENABLES BL, COMBRINK KD, GULGEZE HB, Yu KL, CIVIELLO RL, THURING J, WANG XA, YANG Z, ZADJURA L, MARINO A, KADOW KF, CIANCI CW, CLARKE J, GENOVESI EV, MEDINA I, LAMB L. Respiratory syncytial virus fusion inhibitors. Part 7: structure-activity relationships associated with a series of isatin oximes that demonstrate antiviral activity in vivo. Bioorg Med Chem Lett 2009; 19: 4857-4862.